LINZESS
NDC 50090-8108, linaclotide, capsule, gelatin coated, from A-S Medication Solutions.
- Product NDC
- 50090-8108
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202811
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LINACLOTIDE145 ug/1
Pharmacologic classes
Guanylate Cyclase Activators [MoA]; Guanylate Cyclase-C Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-8108-0 | 50090810800 | 1 BOTTLE in 1 CARTON (50090-8108-0) / 30 CAPSULE, GELATIN COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/2d09771d-69da-4c9d-92b6-74374ffa130f
Use it
Look up 50090-8108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-8108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.